Table 6.

Multivariable analysis of factors associated with relapse in GCA patients.

Variables at diagnosis	Univariate HR [95% CI]	p	Multivariate HR [95% CI]	p
Male	0.49 [0.30–0.83]	0.01	0.51 [0.27–0.96]	0.04*
Headaches	1.37 [0.91–2.06]	0.13	1.59 [0.90–2.80]	0.11
Weight loss	1.32 [0.89–1.95]	0.17	1.09 [0.65–1.83]	0.74
Abdominal pain	1.65 [0.80–3.41]	0.17	1.43 [0.51–4.03]	0.50
Peripheral musculoskeletal manifestation	1.73 [1.12–2.65]	0.01	1.74 [1.03–2.94]	0.04*
Hypercholesterolemia	1.66 [1.08–2.57]	0.02	1.50 [0.80–2.80]	0.20
Upper limb ischemia	1.96 [0.72–5.34]	0.19	1.17 [0.30–4.56]	0.81
Inflammation of the brachiocephalic trunk	1.62 [0.97–2.71]	0.07	1.61 [0.64–4.07]	0.31
Inflammation of arm arteries	1.39 [0.86–2.24]	0.18	0.89 [0.38–2.10]	0.80
Statin at diagnosis	1.34 [0.86–2.08]	0.19	1.52 [0.75–3.05]	0.24
Methylprednisolone infusion at diagnosis	0.61 [0.32–1.13]	0.12	0.58 [0.27–1.26]	0.17

^*Significant at p < 0.05.

CI, confidence interval; GCA, giant cell arteritis; HR, hazard ratio.